Biomarkers in clinical research on cancer by the use of drug | 98905
International Research Journals

International Research Journal of Biochemistry and Bioinformatics

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Biomarkers in clinical research on cancer by the use of drugs


Charlotte Brian*

A biological molecule that may be found in tissues, physiological fluids, or blood and serves as a biomarker for a disease, condition, or healthy process. To determine how effectively the body responds to a disease or condition therapy, a biomarker may be utilised also known as a signature molecule and a molecular marker. Biomarkers, also known as biological markers, are biological indicators of a condition of biology (Lubin et al., 2008). A biomarker is, according to its official definition, "a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacological responses to a therapeutic intervention”. In order to design an effective treatment intervention, biomarkers are the measurements used to conduct a clinical evaluation, such as blood pressure or cholesterol level. Biomarkers are used to monitor and forecast health conditions in individuals or across groups. To evaluate a person's health or illness condition, biomarkers may be utilised singly or in combination (Jakobsson 2008).

Share this article